Return to content in this issue

 

Dupilumab Remarkably Improved Eustachian Tube Obstruction: A Case of Mepolizumab-Resistant Eosinophilic Otitis Media

Takeshita Y1, Tada Y1, Okano M2, To M3, To Y4

1Department of Pulmonary Medicine, International University of Health and Welfare, Narita Hospital, Chiba, Japan
2Department of Otorhinolaryngology, International University of Health and Welfare, Chiba, Japan
3Department of Laboratory Medicine, Dokkyo Medical University, Saitama Medical Center, Koshigaya City, Saitama, Japan
4Department of Pulmonary Medicine, International University of Health and Welfare, Atami Hospital, Shizuoka, Japan

J Investig Allergol Clin Immunol 2023; Vol 33(1) : 57-58
doi: 10.18176/jiaci.0803

Key words: Dupilumab, Eosinophilic otitis media, Periostin